Which Achalasia Treatment Comes First? How Age, Type and Health Guide the Choice

A woman in her late fifties describes the moment she knew something was wrong: a sip of water at a wedding that simply sat in her chest, refusing to move. A man of twenty-eight tells almost the same story, except his began with bread. Both waited more than a year before someone said the word achalasia, and both then faced the same bewildering menu of achalasia treatment options: a balloon, an operation, an endoscopic tunnel, an injection, or tablets.

The frustrating truth is that the order of those options is not fixed. What comes first for a healthy thirty-year-old with type II disease can look very different from what is offered to an eighty-year-old with heart failure and a widened, baggy esophagus.

This explainer walks through how each treatment works, what the trials actually showed, and how age, achalasia type and general health shift the balance. It will not tell you which to choose. It should help you understand why your team suggests what it does.

What actually happens in achalasia, in plain language

The esophagus is a muscular tube roughly ten inches long, and at its lower end sits a ring of muscle called the lower esophageal sphincter, a valve that stays shut between meals and opens as food arrives. Achalasia is a condition in which the nerve cells that coordinate this system are lost, so the valve fails to relax and the tube above it loses its orderly, wave-like squeeze.

The result is mechanical rather than inflammatory. Food and liquid pool above a door that will not open. Over months and years the esophagus stretches to hold the backlog, which is why a long-standing case can look like a sock on an X-ray rather than a straw. People describe a heaviness behind the breastbone, regurgitation of undigested food hours after eating, night-time coughing, and gradual weight loss. MedlinePlus notes that the condition can develop at any age, though it is most often diagnosed in middle age and later.

Nobody yet knows why the nerve cells disappear. Autoimmune injury and prior viral infection are the leading theories, and Cleveland Clinic describes it as rare, affecting roughly one in every 100,000 people each year. That rarity matters for treatment: many general physicians will see only a handful of cases in a career, so diagnosis often takes time.

Every effective treatment works on the same principle. None restores the lost nerves. Each one instead weakens or opens the tight valve so that gravity, not muscle, can carry food into the stomach. Understanding that single idea makes every option that follows easier to compare, because the question is never “which treatment fixes the nerves” but “which way of loosening the valve suits this person best.”

Do the four stages of achalasia decide treatment? Why type matters more

People searching for the “four stages of achalasia” usually find a radiographic grading system. On a barium swallow, a test in which you drink a chalky liquid that shows up on X-ray, the esophagus is graded from stage I, with little or no widening, through stages II and III, with progressive dilation, to stage IV, where the tube has become so long and floppy that it curves like a sigmoid loop. Stage describes how much the esophagus has stretched, and it is one factor teams weigh, particularly at the far end when a very dilated organ empties poorly regardless of how well the valve is opened.

Stage, however, is not what most modern treatment decisions hinge on. The more influential label is the type, defined by a test called high-resolution manometry, which measures pressure along the esophagus during swallows using a thin catheter passed through the nose. The Chicago classification used in the American College of Gastroenterology (ACG) guideline separates three patterns:

• Type I: the esophageal body is essentially quiet, with no pressure generated.
• Type II: the body compresses the whole column of swallowed liquid at once, a pattern called panesophageal pressurization.
• Type III: the lower esophagus produces spastic, premature contractions.

Why does this matter? The spasm in type III extends higher up the tube than a balloon or a standard surgical cut can reach, which is why the ACG guideline suggests POEM, with its adjustable, longer cut, for type III. Types I and II respond well to all three definitive procedures, so other factors take the lead. Ask which type you have; it is one of the most useful pieces of information you can carry into the conversation.

Pneumatic dilation for achalasia: what happens and who it suits

Pneumatic dilation is the oldest of the three definitive treatments and still one of the three the ACG guideline recommends as a first-line choice in people fit for it. A gastroenterologist passes an endoscope, a flexible tube with a camera, down the throat under sedation, positions a deflated balloon across the tight valve, and inflates it briefly under X-ray guidance to a controlled diameter so that the muscle fibers tear in a deliberate, graded way.

The appeal is obvious. There is no incision, the procedure takes minutes, and most people go home the same day. Mayo Clinic notes that repeat dilations are common in the years that follow, and teams often plan a graded series, starting with a smaller balloon and stepping up only if symptoms persist. This stepwise approach is why the treatment tends to be described as a program rather than a one-off.

The main risk is perforation, a tear through the full thickness of the esophageal wall that requires urgent repair. The ACG guideline puts this at around 2 in 100 procedures in experienced hands. Because of that, Mayo Clinic notes dilation is often used with particular caution in the very young and in anyone who might struggle with an emergency operation, and many teams avoid it in people whose anatomy makes a tear more likely.

Who tends to be steered toward it? Evidence summarized in the ACG guideline suggests outcomes are somewhat better in older adults and in women, and it is a reasonable option when someone prefers to avoid surgery or wants to keep the option of a myotomy in reserve. It suits type I and type II disease better than type III. As always, the balance between the low upfront burden and the likelihood of needing repeat sessions is a conversation, not a rule.

What happens during a Heller myotomy

A myotomy is a cut through a muscle without removing it. In a laparoscopic Heller myotomy, a surgeon works through several small abdominal incisions, using a camera and long instruments, and divides the muscle fibers of the lower esophageal sphincter lengthwise while leaving the inner lining intact. The cut typically extends a short way onto the stomach so that the whole valve loosens.

On its own, a myotomy leaves the stomach free to send acid upward, so surgeons almost always add a partial fundoplication, in which the top of the stomach is wrapped part-way around the lower esophagus to act as a soft anti-reflux flap. The ACG guideline specifically recommends pairing myotomy with this partial wrap rather than a full one, because a complete wrap in someone whose esophagus cannot push would recreate the very obstruction being treated.

The operation is done under general anesthesia. Cleveland Clinic and Johns Hopkins both describe a short hospital stay, usually one or two nights, with a liquid diet at first and a gradual return to soft foods. Risks include bleeding, infection, injury to the esophageal lining, which is usually recognized and repaired during the operation, and the general risks of anesthesia. Longer term, the two main concerns are symptom recurrence and reflux, which the next sections cover.

Heller myotomy has been the surgical standard for decades, and for a fit person of any adult age it remains a first-line option in the ACG guideline. Its particular strength is that the anti-reflux step is built in. Its particular limits are that the cut cannot easily be extended high into the chest, which is relevant for type III, and that it is an abdominal operation rather than an endoscopic one, a distinction that matters more to some people than others.

Achalasia surgery vs POEM: what the trials actually found

Peroral endoscopic myotomy, POEM, is the newest definitive option and the one most often labeled a breakthrough. It achieves the same muscle cut as a Heller myotomy but from inside the esophagus. Under general anesthesia, an endoscopist makes a small opening in the inner lining several inches above the valve, creates a tunnel between the lining and the muscle, cuts the muscle fibers along a chosen length, and then closes the entry point with clips. There is no external incision.

Because the tunnel can be as long as needed, POEM can treat the spastic segment of type III disease that a surgical cut struggles to reach. The ACG guideline suggests POEM over dilation or Heller myotomy for type III on that basis. For types I and II, the guideline treats POEM, Heller myotomy and dilation as comparable first-line choices.

The most cited head-to-head evidence is a European randomized trial published in the New England Journal of Medicine, which compared POEM with laparoscopic Heller myotomy plus partial fundoplication. At two years, clinical success was 83.0 percent with POEM and 81.7 percent with surgery, a difference the authors judged statistically equivalent. The trade-off appeared in reflux: esophagitis on endoscopy was seen in 57 percent of POEM patients versus 20 percent of surgical patients at three months, and 44 percent versus 29 percent at two years.

So the honest comparison is not “new beats old.” The two approaches loosen the valve about equally well over that timeframe. POEM avoids abdominal incisions and reaches higher, but it carries no built-in anti-reflux wrap. Surgery adds the wrap at the cost of an abdominal operation. Which trade-off suits a particular person is exactly the kind of judgment the treating team makes with them.

Achalasia treatment options compared: is there a gold standard?

People often ask which treatment is the gold standard, expecting one answer. The ACG guideline gives a more useful one: for adults who are fit for a procedure, pneumatic dilation, laparoscopic Heller myotomy and POEM are all acceptable first-line treatments, and the choice should reflect the achalasia type, the person’s health and preferences, and the expertise available. Botulinum toxin and oral medicines are placed lower, for those who cannot or will not have a definitive procedure.

Option	How it opens the valve	Anesthesia and setting	Main strengths	Main limitations
Pneumatic dilation	Balloon stretches and tears muscle fibers	Sedation, day procedure	No incision; quick; repeatable	Often needs repeat sessions; perforation risk around 2 in 100 (ACG)
Laparoscopic Heller myotomy	Surgical cut through the muscle plus partial fundoplication	General anesthesia; short hospital stay	Durable; anti-reflux wrap built in	Abdominal operation; limited reach for type III
POEM	Endoscopic tunnel and adjustable-length muscle cut	General anesthesia; short hospital stay	No external incision; reaches spastic segments; preferred for type III (ACG)	Higher reflux esophagitis rates in trials; requires specialized expertise
Botulinum toxin injection	Temporarily paralyzes valve muscle	Sedation, day procedure	Very low risk; useful when unfit for other options	Effect fades over months; repeat injections may scar tissue (Mayo Clinic)
Oral medicines	Relax smooth muscle briefly before meals	Outpatient prescription	Non-invasive	Modest, short-lived effect; side effects such as headache (Mayo Clinic)

Read across the rows and a pattern emerges. The three definitive options trade invasiveness against durability and reflux in different ways; the two conservative options trade safety against effectiveness. No row wins on every column, which is precisely why guidelines decline to crown one.

Where botulinum toxin and oral medicines fit

Botulinum toxin is the same neurotoxin used in other muscle-relaxing treatments. Injected through an endoscope into the lower esophageal sphincter, it blocks the nerve signal that keeps the muscle contracted, so the valve slackens. It is a genuinely low-risk procedure, done under sedation as a day case, and for someone whose heart, lungs or frailty make an operation or dilation unsafe, it can bring real relief.

The catch is time. Mayo Clinic notes that the effect wears off and injections usually need to be repeated, and the ACG guideline recommends against using it as first-line treatment in people who are fit for a definitive procedure. Repeated injections can also cause scarring at the injection site, which Mayo Clinic warns may make a later myotomy more difficult. That is the reason a healthy forty-year-old is rarely offered it first: it can complicate the very operation they may later need.

Oral medicines occupy a similar niche. Two classes, nitrates and calcium channel blockers, relax smooth muscle and can briefly lower valve pressure when taken before meals. Mayo Clinic describes their effect as limited and often accompanied by side effects such as headache or swollen ankles, and the ACG guideline positions them for people who have failed or cannot have other treatments, sometimes as a bridge while waiting. Any decision about starting, continuing or changing such a medicine belongs entirely with the prescribing clinician.

It helps to think of these two options as valuable tools for a specific group rather than weaker versions of the main treatments. For an older adult with serious other illness, or someone who has decided against procedures after informed discussion, they can be exactly right. For most people fit for a procedure, they are usually a detour rather than a destination.

Which achalasia treatment options come first, and who is asked to wait?

Pulling the threads together, teams tend to weigh four things in roughly this order. First, is the person fit for general anesthesia or, at minimum, for an emergency operation should a dilation tear the esophagus? If not, botulinum toxin or medicines move to the front. Cleveland Clinic notes achalasia is most often diagnosed between the ages of 25 and 60, but it also appears in the very young and the very old, and fitness, not birth year, is what counts.

Second, what type is it? Type III shifts the balance toward POEM, per the ACG guideline. Types I and II leave all three definitive options on the table.

Third, what does the esophagus look like? A grossly dilated, sigmoid-shaped organ at radiographic stage IV empties poorly even after a good myotomy, and teams may discuss more extensive surgery, though most people are still offered a valve-opening procedure first.

Fourth, what does the person value? Some would rather accept a program of repeat dilations than a single operation. Others want the most durable single procedure and are willing to manage reflux afterward. Someone with existing severe reflux may lean toward the operation that includes an anti-reflux wrap; someone anxious about abdominal surgery may lean toward POEM or dilation.

Who is asked to wait? People who have had recent botulinum toxin, since scarring may need to settle before myotomy is planned; people with an unstable heart or lung condition until it is optimized; and occasionally people whose diagnosis is uncertain, because pseudoachalasia, an obstruction from a tumor at the junction that mimics achalasia, must be excluded first. Waiting in these cases is not delay for its own sake; it is the team protecting the outcome.

Achalasia recovery time: what the first days and weeks look like

Recovery depends on which route you take, and every team has its own protocol, so treat what follows as a typical shape rather than a schedule.

After pneumatic dilation, most people are observed for a few hours, often have a swallow X-ray to check for a leak, and go home the same day. Chest soreness for a day or two is common. Eating usually resumes with liquids and progresses as comfort allows.

After Heller myotomy or POEM, Johns Hopkins and Cleveland Clinic describe a hospital stay of about one to two nights, with a contrast swallow the next morning to confirm the lining is sealed before anything is taken by mouth. The first days are liquids only, followed by pureed and then soft foods over roughly one to two weeks, and a gradual return to a normal diet as the team advises. Shoulder-tip pain from residual gas is common after laparoscopic surgery; a sore throat is common after POEM. Most people are back to desk work within a week or two and to strenuous activity when their surgeon clears it.

Symptom relief itself is often immediate: many describe the first easy swallow of water as startling. Others notice a slower improvement over weeks as the stretched esophagus, freed of its backlog, gradually empties better. Weight that was lost typically returns once eating normalizes.

Two practical points deserve emphasis. Eat upright and stay upright for a while afterward, because the esophagus still cannot push; gravity is now doing the work. And keep every follow-up appointment even if you feel well. Some teams schedule a timed barium swallow or manometry in the months after treatment to check emptying objectively, since symptoms alone can understate residual obstruction.

Reflux after myotomy: the trade-off worth understanding before you choose

Every treatment that loosens the valve also weakens the barrier that keeps stomach acid where it belongs. Reflux is therefore not a complication of achalasia treatment so much as its shadow, and the degree varies by procedure.

Surgery addresses this directly with the partial fundoplication. POEM does not, and the randomized trial described earlier found reflux esophagitis on endoscopy in 44 percent of POEM patients at two years compared with 29 percent after surgery with a wrap. Pneumatic dilation sits somewhere in between; it tears the valve less completely, so reflux is generally less frequent, though it certainly occurs.

Two features of post-treatment reflux make it worth taking seriously. First, it is often silent. An esophagus that has lost its nerve supply may not register heartburn, so the ACG guideline recommends objective testing, such as endoscopy or pH monitoring, after treatment rather than relying on symptoms alone. Second, untreated acid exposure over years can inflame and scar the lining, and Mayo Clinic notes that people with long-standing achalasia carry a modestly raised risk of esophageal cancer, which is one more reason for structured follow-up.

Management is usually straightforward. Many people are advised to take an acid-suppressing medicine of the proton pump inhibitor class, sometimes long term, and lifestyle steps such as avoiding late meals and raising the head of the bed help. Whether, when and for how long such a medicine is used is a decision for the prescribing clinician.

None of this is an argument against POEM. It is an argument for going in with eyes open. Someone who understands that the price of a tunnel with no incision may be years of acid suppression can make a genuinely informed choice, and so can someone who decides that an abdominal operation with a built-in wrap is worth the extra invasiveness.

Will achalasia ever go away? Living with it long term

Asked plainly: no, achalasia does not resolve on its own, and no current treatment restores the missing nerve cells. Mayo Clinic and MedlinePlus both describe it as a chronic condition that is treated rather than reversed. What treatment does, and often does very well, is remove the obstruction so that eating becomes normal or close to it for years.

Because the underlying problem persists, symptoms can return. The valve muscle may partially heal after dilation, a myotomy may scar, or a dilated esophagus may empty sluggishly despite an open valve. The five-year European trial comparing pneumatic dilation with Heller myotomy, summarized in the ACG guideline, found both maintained good outcomes in most patients, with success rates in the low eighties percent for each, but that still means roughly one in five needed something more. Repeat dilation, a second myotomy, or switching from one approach to another are all established next steps, and prior treatment does not close the door on the others.

At the far end sits end-stage disease: a massively dilated, tortuous esophagus that will not empty even with an open valve, leading to malnutrition, aspiration or recurrent pneumonia. Here teams may discuss esophagectomy, the surgical removal of the esophagus with reconstruction using stomach or bowel. It is a major operation reserved for a small minority, and the ACG guideline treats it as a last resort after less invasive options have been exhausted.

Living well long term therefore means three habits: eating upright and chewing well, staying alert to gradual change rather than dismissing it, and keeping the periodic checks your team recommends. Achalasia is a lifelong companion, but for most people it becomes a background one.

What people often get wrong about achalasia treatment

Myth: the newest treatment is automatically the best. POEM is a real advance, particularly for type III disease, but the head-to-head trial with surgery found essentially equal relief at two years alongside more reflux. “Newest” and “best for me” are different questions.

Myth: surgery is the last resort. In achalasia the definitive procedures are first-line for anyone fit enough to have them. It is botulinum toxin and tablets that guidelines hold back for those who cannot.

Myth: the stage on the X-ray decides everything. Stage describes how stretched the esophagus is and matters most at the extreme end. The manometry type usually carries more weight in choosing between dilation, Heller myotomy and POEM.

Myth: if swallowing feels fine after treatment, follow-up is unnecessary. Reflux after myotomy is frequently silent, and a poorly emptying esophagus can feel deceptively comfortable. Objective testing exists precisely because symptoms can mislead.

Myth: achalasia is a form of severe acid reflux, or is caused by stress. It is a nerve disorder of the esophageal muscle. Stress does not cause it, and acid-suppressing medicine does not treat the obstruction, though it may be prescribed afterward for the reflux that treatment can create.

Myth: having one treatment rules out the others. Dilation after failed myotomy, myotomy after failed dilation, and POEM after either are all recognized pathways. The main exception is that repeated botulinum toxin may make later surgery technically harder, which is why it is used selectively.

Myth: it will come back no matter what, so why bother. Most people in long-term trial follow-up maintained good swallowing for years, and recurrence, when it happens, is usually treatable. Untreated achalasia, by contrast, progresses toward malnutrition and aspiration.

Questions to ask your care team

A good consultation about achalasia rarely ends with a single instruction. It ends with a shared understanding of why one path suits you. These questions tend to open that conversation.

• Which type of achalasia do I have on manometry, and how does that shape the options you are suggesting?
• How dilated is my esophagus on the barium study, and does that change anything about the plan?
• Has pseudoachalasia, a blockage from another cause, been ruled out, and how?
• Am I a candidate for pneumatic dilation, Heller myotomy and POEM, or does something about my health narrow the list?
• If you are recommending one over the others, what is the main reason, and what would make you reconsider?
• How many of these procedures does this team perform, and what happens if a perforation or leak occurs?
• What is the plan for reflux afterward: will I be tested for it even if I feel fine, and for how long might I need acid suppression?
• What does recovery look like in your protocol, week by week, and when should I expect to eat normally?
• If symptoms return in a few years, what would the next step most likely be?
• Which of my current medicines or conditions matter for anesthesia, and do any need adjusting beforehand by the prescribing doctor?
• Would getting a second opinion delay treatment in a way that matters, or is there time?

Write the answers down or bring someone who will. The details that feel obvious in the room tend to blur by the time you are deciding at the kitchen table. And remember that “I would like to think about it” is a complete and reasonable response; achalasia is chronic, not an emergency, and a few weeks of reflection rarely changes what is possible.

When to call your doctor

Achalasia itself progresses slowly, but both the untreated condition and its treatments can produce situations that need prompt attention. Knowing which is which spares needless worry and prevents dangerous delay.

Seek emergency care immediately if, in the hours or days after pneumatic dilation, POEM or a myotomy, you develop severe or worsening chest pain, pain that spreads to the neck or shoulder with fever, a racing heart, shortness of breath, or a feeling of air trapped under the skin of the neck or chest. These can signal a perforation or leak, which is uncommon but must be repaired urgently. Do not wait to see whether it settles.

Call your care team the same day for vomiting blood or passing black stools; a sudden inability to swallow even liquids or saliva; a fever above what your team told you to expect after a procedure; or new coughing, choking or wheezing at night, which can indicate regurgitated food entering the airway.

Arrange a routine appointment if swallowing gradually worsens again after a period of relief, if you lose weight without trying, if heartburn or a sour taste becomes frequent despite prescribed medicine, or if you find yourself eating more slowly or avoiding certain foods again. Gradual change is exactly what the condition does when it recurs, and it is far easier to address early.

Finally, if you are living with achalasia and have not had a review in more than a year, use that as a prompt to check in. Every recommendation in this article sits underneath one principle: the decision about what to do, when, and in what order belongs with you and the team who knows your esophagus, your health and your priorities.

Frequently asked questions

What are the four stages of achalasia?

The four stages describe how much the esophagus has widened on a barium X-ray, from stage I with little dilation to stage IV, where the tube is so stretched that it curves like a sigmoid loop. Stage helps teams judge how well the esophagus will empty after treatment, but the manometry type, I, II or III, usually carries more weight in choosing between dilation, Heller myotomy and POEM.

What is the gold standard treatment for achalasia?

There is no single gold standard. Current American College of Gastroenterology guidance treats pneumatic dilation, laparoscopic Heller myotomy and POEM as comparable first-line options for people fit for a procedure, with POEM suggested for type III disease. The right choice depends on achalasia type, age, other health conditions, how dilated the esophagus is, and what the person values, decided together with the treating team.

What are the newest treatment options for achalasia?

POEM, peroral endoscopic myotomy, is the newest definitive treatment. It cuts the valve muscle from inside the esophagus through an endoscopic tunnel, with no external incision, and can reach spastic segments higher in the chest. Trials show relief comparable to surgical myotomy at two years but more reflux afterward. It is an established option now rather than experimental, though it requires specialized expertise.

Will achalasia ever go away?

No. Achalasia is a chronic nerve disorder of the esophagus, and no current treatment restores the lost nerve cells. Treatment opens the tight valve so that eating becomes normal or near normal, often for many years, but symptoms can return and further treatment may be needed. Long-term follow-up, upright eating habits and attention to reflux are the routine parts of living with it.

What is the usual achalasia type 2 treatment?

Type II achalasia responds well to all three definitive options, so pneumatic dilation, laparoscopic Heller myotomy and POEM are each considered reasonable first-line choices in the ACG guideline. Because the type does not tip the balance, other factors take over: age, fitness for anesthesia, existing reflux, how dilated the esophagus is, and personal preference about invasiveness versus the likelihood of repeat procedures.

How does achalasia surgery vs POEM compare for reflux?

Surgery includes a partial fundoplication, a soft wrap of stomach around the esophagus that limits acid rising; POEM does not. In the randomized trial comparing them, reflux esophagitis was found in 44 percent of POEM patients versus 29 percent of surgical patients at two years. Many people after POEM are advised long-term acid suppression and objective testing, a decision made by the treating clinician.

Is pneumatic dilation for achalasia painful, and how often is it repeated?

It is done under sedation, so the procedure itself is not felt, though chest soreness for a day or two afterward is common. Mayo Clinic notes that repeat dilations are frequently needed in the following years, and teams often plan a graded series with progressively larger balloons. The main risk is perforation, around 2 in 100 procedures according to the ACG guideline.

What is the typical achalasia recovery time after myotomy?

Johns Hopkins and Cleveland Clinic describe a hospital stay of roughly one to two nights after Heller myotomy or POEM, a contrast swallow to check for leaks before eating, then liquids progressing to soft foods over about one to two weeks. Most people return to desk work within a week or two. Individual protocols vary, so the team’s specific instructions take precedence.

Is botulinum toxin a good first treatment for achalasia?

For people fit for a definitive procedure, guidelines advise against it as first-line, because the effect fades over months and repeated injections can scar the muscle and make later surgery harder. For someone too frail or unwell for dilation or myotomy, or who declines them after informed discussion, it is a low-risk way to ease swallowing. The choice sits with the treating team.

Does age decide which achalasia treatment comes first?

Age influences but does not dictate the choice. Fitness for anesthesia and for an emergency operation matters more than birth year. Evidence summarized in the ACG guideline suggests pneumatic dilation performs somewhat better in older adults, while younger people are sometimes steered toward a myotomy for durability. An older adult in good health can still be offered any of the three definitive procedures.

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.